Literature DB >> 23167234

Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves.

Petra E Dijkman1, Anita Driessen-Mol, Linda M de Heer, Jolanda Kluin, Lex A van Herwerden, Berhard Odermatt, Frank P T Baaijens, Simon P Hoerstrup.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Living tissue-engineered heart valves (TEHVs) based on rapidly degrading scaffolds and autologous cells might overcome the limitations of today's valve substitutes. Following minimally invasive trans-apical implantation into an ovine model, TEHVs showed adequate in-vivo functionality, but a thickening of the leaflets was observed. In order to evaluate the impact of the substantial tissue deformations of TEHVs associated with the crimping procedure during minimally invasive delivery, trans-apical and conventional implantation technologies were compared in an ovine model.
METHODS: Trileaflet heart valves (n=11) based on PGA/P4HB-scaffolds, integrated into self-expandable stents, were engineered from autologous ovine vascular-derived cells. After in-vitro culture, the TEHVs were either implanted surgically (n=5), replacing the native pulmonary valve, or delivered trans-apically (n=6) into the orthotopic pulmonary valve position. In-vivo functionality was assessed by echocardiography and by angiography for up to eight weeks. The tissue compositions of the explanted TEHVs and corresponding control valves were analyzed.
RESULTS: TEHV implantations were successful in all cases. Independent of the implantation method, the explants demonstrated a comparable layered tissue formation with thickening and deposited fibrous layers. Active remodeling of these layers was evident in the explants, as indicated by vascularization of the walls, invasion of the host cells, and the formation of a luminal endothelial layer on the TEHV leaflets.
CONCLUSION: This direct comparison of trans-apical and conventional surgical implantation techniques showed that crimping had no adverse effect on the integrity or functional outcome of TEHVs. This suggests that a thickening of TEHVs in vivo is neither caused by nor enhanced by the crimping procedure, but represents a functional tissue remodeling process.

Entities:  

Mesh:

Year:  2012        PMID: 23167234

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  10 in total

Review 1.  Heart Valve Replacements with Regenerative Capacity.

Authors:  Petra E Dijkman; Emanuela S Fioretta; Laura Frese; Francesco S Pasqualini; Simon P Hoerstrup
Journal:  Transfus Med Hemother       Date:  2016-07-26       Impact factor: 3.747

Review 2.  On the Mechanics of Transcatheter Aortic Valve Replacement.

Authors:  Lakshmi P Dasi; Hoda Hatoum; Arash Kheradvar; Ramin Zareian; S Hamed Alavi; Wei Sun; Caitlin Martin; Thuy Pham; Qian Wang; Prem A Midha; Vrishank Raghav; Ajit P Yoganathan
Journal:  Ann Biomed Eng       Date:  2016-11-21       Impact factor: 3.934

Review 3.  Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity.

Authors:  Emanuela S Fioretta; Sarah E Motta; Valentina Lintas; Sandra Loerakker; Kevin K Parker; Frank P T Baaijens; Volkmar Falk; Simon P Hoerstrup; Maximilian Y Emmert
Journal:  Nat Rev Cardiol       Date:  2020-09-09       Impact factor: 32.419

Review 4.  Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions.

Authors:  Daniel Y Cheung; Bin Duan; Jonathan T Butcher
Journal:  Expert Opin Biol Ther       Date:  2015-06-01       Impact factor: 4.388

5.  Hemodynamic Characterization of a Mouse Model for Investigating the Cellular and Molecular Mechanisms of Neotissue Formation in Tissue-Engineered Heart Valves.

Authors:  Iyore A James; Tai Yi; Shuhei Tara; Cameron A Best; Alexander J Stuber; Kejal V Shah; Blair F Austin; Tadahisa Sugiura; Yong-Ung Lee; Joy Lincoln; Aaron J Trask; Toshiharu Shinoka; Christopher K Breuer
Journal:  Tissue Eng Part C Methods       Date:  2015-05-29       Impact factor: 3.056

6.  6-month aortic valve implantation of an off-the-shelf tissue-engineered valve in sheep.

Authors:  Zeeshan Syedain; Jay Reimer; Jillian Schmidt; Matthew Lahti; James Berry; Richard Bianco; Robert T Tranquillo
Journal:  Biomaterials       Date:  2015-09-11       Impact factor: 12.479

7.  Tubular heart valves from decellularized engineered tissue.

Authors:  Zeeshan H Syedain; Lee A Meier; Jay M Reimer; Robert T Tranquillo
Journal:  Ann Biomed Eng       Date:  2013-07-30       Impact factor: 3.934

Review 8.  Comparing the Role of Mechanical Forces in Vascular and Valvular Calcification Progression.

Authors:  Madeleine A Gomel; Romi Lee; K Jane Grande-Allen
Journal:  Front Cardiovasc Med       Date:  2019-01-10

9.  Differential Leaflet Remodeling of Bone Marrow Cell Pre-Seeded Versus Nonseeded Bioresorbable Transcatheter Pulmonary Valve Replacements.

Authors:  Emanuela S Fioretta; Valentina Lintas; Anna Mallone; Sarah E Motta; Lisa von Boehmer; Petra E Dijkman; Nikola Cesarovic; Etem Caliskan; Héctor Rodriguez Cetina Biefer; Miriam Lipiski; Mareike Sauer; Matilde Putti; Henk M Janssen; Serge H Söntjens; Anthal I P M Smits; Carlijn V C Bouten; Maximilian Y Emmert; Simon P Hoerstrup
Journal:  JACC Basic Transl Sci       Date:  2019-12-11

Review 10.  Tissue Engineered Transcatheter Pulmonary Valved Stent Implantation: Current State and Future Prospect.

Authors:  Xiling Zhang; Thomas Puehler; Jette Seiler; Stanislav N Gorb; Janarthanan Sathananthan; Stephanie Sellers; Assad Haneya; Jan-Hinnerk Hansen; Anselm Uebing; Oliver J Müller; Derk Frank; Georg Lutter
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.